Josephine A Muhairwe (Josephine Muhairwe)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Antiretroviral Therapy

Cross Sectional

Top Venues

Journal of the International AIDS Society

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer Anne Brown, Bienvenu L Nsakala, Kuena Mokhele, Itumeleng Rakuoane, Josephine A Muhairwe, Tracy R Glass, Alain Amstutz, Nadine Tschumi, Jennifer M Belus, Thomas Klimkait, Niklaus Daniel Labhardt
Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho. HIV medicine (2022)
Matthew L Romo, Ellen Brazier, Dominique Mahambou-Nsondé, Reneé De Waal, Christine Wiltshire Sekaggya, Cleophas Chimbetete, Winnie R Muyindike, Gad Murenzi, Cordelia Kunzekwenyika, Thierry Tiendrebeogo, Josephine A Muhairwe, Patricia Lelo, Anastase Dzudie, Christella Twizere, Idiovino Rafael, Oliver Chukwujekwu Ezechi, Lameck Diero, Marcel Yotebieng, Lukas Fenner, Kara K Wools-Kaloustian, N Sarita Shah, Denis Nash, null null
Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa. Journal of the International AIDS Society 25 (7) (2022)
Alain Amstutz, Thabo Ishmael Lejone, Lefu Khesa, Mathebe Kopo, Mpho Kao, Josephine A Muhairwe, Moniek Bresser, Fabian Räber, Thomas Klimkait, Manuel Battegay, Tracy Renée Glass, Niklaus Daniel Labhardt
Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial. PLoS medicine 18 (10) (2021)
Alain Amstutz, Bienvenu Lengo Nsakala, Fiona Vanobberghen, Josephine A Muhairwe, Tracy Renée Glass, Tilo Namane, Tlali Mpholo, Manuel Battegay, Thomas Klimkait, Niklaus Daniel Labhardt
Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho. PLoS medicine 17 (9) (2020)